Ketorolac versus Magnesium Sulfate in Migraine Headache Pain Management; a Preliminary Study
- PMID: 28286809
- PMCID: PMC5325888
Ketorolac versus Magnesium Sulfate in Migraine Headache Pain Management; a Preliminary Study
Abstract
Introduction: Migraine is a common cause of emergency department (ED) visits. To date, there is no recommended drug of choice for pain management of these patients. In the present study, we aimed to evaluate the effectiveness of ketorolac and magnesium sulfate in this regard.
Methods: This is a cross-sectional study performed on all 18 - 60 year-old patients, visiting two different EDs with complaint of moderate to severe migraine headache. Patients were treated with 30 mg ketorolac in one hospital and 1 gram magnesium sulfate in the other. Pain scores were assessed on arrival, 1 and 2 hours after drugs administration and quality of pain management was compared between two groups using SPSS 22.
Results: 70 patients with the mean age of 36.4 ± 11.4 years were enrolled (51.4% male). The two groups were similar regarding baseline characteristics (p > 0.05). The improvement in pain score in magnesium sulfate group was greater than Ketorolac group after both one hour (6 vs 3; p < 0.001) and two hours (7 vs 5; p < 0.001).
Conclusion: It seems that both ketorolac and magnesium sulfate are significantly effective in pain control of patients with migraine headache presenting to the emergency department. Magnesium sulfate was superior to ketorolac both one and two hours after drug administration.
Keywords: Magnesium sulfate; emergency department; ketorolac; migraine disorders; pain management.
Conflict of interest statement
All authors declare that there is no conflict of interest in this study.
Figures
Similar articles
-
Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study.Korean J Pain. 2017 Jul;30(3):176-182. doi: 10.3344/kjp.2017.30.3.176. Epub 2017 Jun 30. Korean J Pain. 2017. PMID: 28757917 Free PMC article.
-
Comparing the Therapeutic Effects of Dexamethasone-Metoclopramide with Ketorolac in Relieving Headache in Patients with Acute Migraine Attacks Presenting to the Emergency Department.Adv J Emerg Med. 2019 Mar 9;3(2):e17. doi: 10.22114/AJEM.v0i0.142. eCollection 2019 Spring. Adv J Emerg Med. 2019. PMID: 31172128 Free PMC article.
-
Assessment of Magnesium Sulfate Infusion in Combination with Ketorolac for the Pain Management in Intertrochanteric Fractures; A Randomized Clinical Trial.Arch Bone Jt Surg. 2023;11(6):414-420. doi: 10.22038/ABJS.2023.64778.3109. Arch Bone Jt Surg. 2023. PMID: 37404294 Free PMC article.
-
Intravenous Magnesium Sulfate to Treat Acute Headaches in the Emergency Department: A Systematic Review.Headache. 2019 Nov;59(10):1674-1686. doi: 10.1111/head.13648. Epub 2019 Sep 30. Headache. 2019. PMID: 31566727
-
Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications.Headache. 2012 Mar;52(3):467-82. doi: 10.1111/j.1526-4610.2012.02097.x. Headache. 2012. PMID: 22404708 Review.
Cited by
-
Current Approach to Undifferentiated Headache Management in the Emergency Department.Curr Pain Headache Rep. 2019 Mar 14;23(4):26. doi: 10.1007/s11916-019-0765-1. Curr Pain Headache Rep. 2019. PMID: 30868276 Review.
-
Comparison of the efficacy of intranasal ketamine versus intravenous ketorolac on acute non-traumatic headaches: a randomized double-blind clinical trial.Head Face Med. 2022 Jan 3;18(1):1. doi: 10.1186/s13005-021-00303-0. Head Face Med. 2022. PMID: 34980184 Free PMC article. Clinical Trial.
-
Non-opioid Intravenous Drugs for Pain Management in Patients Presenting with Acute Migraine Pain in the Emergency Department: A Comprehensive Literature Review.Anesth Pain Med. 2022 Nov 22;12(5):e132904. doi: 10.5812/aapm-132904. eCollection 2022 Oct. Anesth Pain Med. 2022. PMID: 36937180 Free PMC article. Review.
-
Intravenous Magnesium Sulfate for Pain Management in Patients with Acute Renal Colic; a Randomized Clinical Trial.Arch Acad Emerg Med. 2019 Dec 28;8(1):e5. eCollection 2020. Arch Acad Emerg Med. 2019. PMID: 32021986 Free PMC article.
-
Evaluation of the Effects of Oral Magnesium Sachet on the Prevention of Spinal Anesthesia-Induced Headache After Cesarean Section: A Randomized Clinical Trial.Anesth Pain Med. 2022 Mar 22;12(1):e121834. doi: 10.5812/aapm.121834. eCollection 2022 Feb. Anesth Pain Med. 2022. PMID: 35433384 Free PMC article.
References
-
- Baratloo A, Negida A, El Ashal G, Behnaz N. Intravenous Caffeine for the Treatment of Acute Migraine: A Pilot Study. Journal of Caffeine Research. :2015.
LinkOut - more resources
Full Text Sources